ArticleACS pharmacology & translational science2024

A Novel Liver Cancer-Selective Histone Deacetylase Inhibitor Is Effective against Hepatocellular Carcinoma and Induces Durable Responses with Immunotherapy.

Bocheng Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.